Cosmos Holdings Launches Mosept-Oral Antiseptic Spray Designed to be Effective Against Bacteria and Certain Viral Pathogens   New proprietary formula for the symptomatic relief of pain and irritated sore throat Initial launch in 3,500 pharmacies in Greece with plans to expand to the UK, Germany, the Netherlands, France, Italy, Spain, Cyprus, Canada and the Middle East CHICAGO, April 08, 2021 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the Company") (OTCQX: COSM), a vertically integrated, international pharmaceutical company with a proprietary line of branded and generic pharmaceuticals, nutraceuticals, OTC medications ...

                 Cosmos Holdings Launches Osteodome in EU   New Proprietary Dietary Supplement Contributes to NormalBone and Cartilage Health and Joint Flexibility Osteodome Is Second Product to Be Marketed throughout the UKDuring First Quarter 2021 EU Distribution Network Grows to 1500 Pharmacies with Access to Additional 50,000 CHICAGO, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the company") (OTCQX: COSM), a vertically integrated, international pharmaceutical company with a proprietary line of branded and generic pharmaceuticals, nutraceuticals, OTC medications and ...

Cosmos Holdings Launches New Proprietary Enhanced Dietary Supplement CHICAGO, Jan. 11, 2021 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the company") (OTCQX: COSM), a vertically integrated international pharmaceutical company with a proprietary line of branded and generic pharmaceuticals, nutraceuticals, OTC medications and an extensive, established EU distribution network, today announced the launch of a new, proprietary enhanced dietary supplement, Bodyguard, a targeted action formula for strengthening the immune system and reducing fatigue. Designed and developed by the company’s wholly owned pharmaceutical subsidiary, Doc ...

Cosmos Holdings Announces December 4th Virtual Bell Ringing to Open Trading on the OTCQX Best Market CHICAGO, Dec. 04, 2020 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the company") (OTCQX: COSM), a vertically integrated international pharmaceutical company with a proprietary line of branded and generic pharmaceuticals, nutraceuticals, OTC medications and an extensive, established EU distribution network, participated in a virtual “Open the Market” on the OTCQX® Best Market today at 9:30 a.m. EST. The virtual bell ringing can be viewed on the ...

CHICAGO, November 25, 2020 -- Cosmos Holdings, Inc. (“the company") (OTCQX: COSM), a vertically integrated international pharmaceutical company with a proprietary line of branded and generic pharmaceuticals, nutraceuticals, OTC medications and an extensive, established EU distribution network, today announced it has qualified to trade on the OTCQX® Best Market; the company has upgraded to OTCQX from the OTCQB® Venture Market and begins trading today on OTCQX under the symbol “COSM.” U.S. investors can find current financial disclosures and Real-Time Level ...